NCT00008099View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Resected or Locally Advanced Unresectable Pancreatic Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

May 31, 1998

Primary Completion Date

March 31, 2001

Study Completion Date

February 29, 2004

Conditions
Pancreatic Cancer
Interventions
BIOLOGICAL

MUC1 antigen/SB AS-2

Trial Locations (1)

15213

University of Pittsburgh Cancer Institute, Pittsburgh

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Pittsburgh

OTHER

NCT00008099 - Vaccine Therapy in Treating Patients With Resected or Locally Advanced Unresectable Pancreatic Cancer | Biotech Hunter | Biotech Hunter